Form 4: Merck Executive Sanat Chattopadhyay Reports Stock Acquisition from Performance Share Units

Executive Vice President of Merck & Co., Sanat Chattopadhyay, reports acquiring shares of common stock following the satisfaction of performance criteria for performance share units.

Summary

• Sanat Chattopadhyay, an Executive Vice President at Merck & Co., reported a transaction on January 27, 2025.
• He acquired 28,136 shares of Merck's common stock at a price of $97.94 per share.
• This acquisition was due to the distribution of net after-tax shares from performance share units granted on March 31, 2022.
• The performance shares were paid out at 169% of the target awards and include dividends accrued over the three-year performance period ending December 31, 2024.
• Following the transaction, Chattopadhyay directly owns 78,758 shares of common stock.
• He also indirectly owns 26,575 shares through a 2022 Grantor Retained Annuity Trust (GRAT), 46,995 shares through a 2023 GRAT, and 33,000 shares through a 2024 GRAT, over which he maintains complete investment control as the sole trustee.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The executive acquired shares due to the vesting of performance share units, which suggests the company met or exceeded its performance targets. The payout at 169% of target is a positive indicator.

Positives

• The vesting of performance share units at 169% of target suggests strong performance relative to the set goals.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, providing transparency to investors about insider activity. It reflects compensation practices tied to performance.

Stakeholder Impact

• Shareholders may view the vesting of performance share units positively, as it indicates that company performance goals were achieved.

Key Dates